SCHEMBL6476183

SCHEMBL6476183

COc1cc(N(C)C(=O)N(C)C(Cc2ccccc2)C(=O)OCCCCCCC(c2cccnc2)c2cccnc2)cc(OC)c1OC

nearest known ligand 0.41

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 3/20 0.41
PDE4D Q08499 2/20 0.37
MAPK1 P28482 1/20 0.37
GFER P55789 1/20 0.36
FKBP1A P62942 4/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
HPGD P15428 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6473445 0.99 TBXAS1 (0.39) TBXAS1PDE4DMAPK1GFERFKBP1A
SCHEMBL8462850 0.88 FKBP1A (0.40) FKBP1A
SCHEMBL3670538 0.81 FKBP1A (0.49) TBXAS1FKBP1AKDM4EALDH1A1POLB
SCHEMBL3675773 0.80 FKBP1A (0.46) PDE4DFKBP1AKDM4EALDH1A1POLB
SCHEMBL6471963 0.74 FKBP1A (0.53) FKBP1A
SCHEMBL7173487 0.68 GFER (0.41) GFERFKBP1ACYP1A2CYP2C19
SCHEMBL7173479 0.68 GFER (0.41) GFERFKBP1ACYP1A2CYP2C19
SCHEMBL9549768 0.65 TBXAS1 (0.46) TBXAS1PDE4DALDH1A1CYP1A2
SCHEMBL18179929 0.64 L3MBTL1 (0.45) MAPK1KDM4EALDH1A1
SCHEMBL9549621 0.64 TBXAS1 (0.44) TBXAS1PDE4DALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0941113-A1 METHODS AND COMPOSITIONS FOR STIMULATING NEURITE GROWTH USING COMPOUNDS WITH AFFINITY FOR FKBP12 IN COMBINATION WITH NEUROTROPHIC FACTORS Vertex Pharmaceuticals Incorporated (US) 1999-09-15 EP claimed
WO-1998020893-A1 METHODS AND COMPOSITIONS FOR STIMULATING NEURITE GROWTH USING COMPOUNDS WITH AFFINITY FOR FKBP12 IN COMBINATION WITH NEUROTROPHIC FACTORS VERTEX PHARMACEUTICALS INCORPORATED (US) 1998-05-22 WO claimed
WO-2005007162-A1 COMPOUNDS AUGMENTING THE ACTIVITY OF ANTIBACTERIAL AGENTS VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-01-27 WO disclosed